Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 6
2016 4
2017 9
2018 4
2019 6
2020 6
2021 3
2022 7
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Snus: a compelling harm reduction alternative to cigarettes.
Clarke E, Thompson K, Weaver S, Thompson J, O'Connell G. Clarke E, et al. Among authors: o connell g. Harm Reduct J. 2019 Nov 27;16(1):62. doi: 10.1186/s12954-019-0335-1. Harm Reduct J. 2019. PMID: 31775744 Free PMC article. Review.
Circulating leucocytes perpetuate stroke-induced aortic dysfunction.
Asano S, O'Connell GC, Lemaster KC, DeVallance ER, Branyan KW, Simpkins JW, Frisbee JC, Barr TL, Chantler PD. Asano S, et al. Among authors: o connell gc. Exp Physiol. 2017 Oct 1;102(10):1321-1331. doi: 10.1113/EP086510. Epub 2017 Sep 2. Exp Physiol. 2017. PMID: 28737253 Free PMC article.
E-Cigarette Aerosol Deposition and Disposition of [11C]Nicotine Using Positron Emission Tomography: A Comparison of Nicotine Uptake in Lungs and Brain Using Two Different Nicotine Formulations.
Wall A, Roslin S, Borg B, McDermott S, Walele T, Nahde T, O'Connell G, Thompson J, Lubberink M, Antoni G. Wall A, et al. Among authors: o connell g. Pharmaceuticals (Basel). 2022 Mar 17;15(3):367. doi: 10.3390/ph15030367. Pharmaceuticals (Basel). 2022. PMID: 35337164 Free PMC article.
A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes.
Chapman F, McDermott S, Rudd K, Taverner V, Stevenson M, Chaudhary N, Reichmann K, Thompson J, Nahde T, O'Connell G. Chapman F, et al. Among authors: o connell g. Psychopharmacology (Berl). 2022 Sep;239(9):2931-2943. doi: 10.1007/s00213-022-06178-6. Epub 2022 Jun 23. Psychopharmacology (Berl). 2022. PMID: 35732751 Free PMC article. Clinical Trial.
Reductions in biomarkers of exposure to selected harmful and potentially harmful constituents following exclusive and partial switching from combustible cigarettes to myblu™ electronic nicotine delivery systems (ENDS).
Morris P, McDermott S, Chapman F, Verron T, Cahours X, Stevenson M, Thompson J, Chaudhary N, O'Connell G. Morris P, et al. Among authors: o connell g. Intern Emerg Med. 2022 Mar;17(2):397-410. doi: 10.1007/s11739-021-02813-w. Epub 2021 Aug 26. Intern Emerg Med. 2022. PMID: 34435305 Free PMC article. Clinical Trial.
49 results